Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGXSWX:MEDX +1.25%67 3-Year Share Buyback Ratio is 0.20 as of Jun. 2026, which is 33% below its 10-year median of 0.30. GuruFocus rates XSWX:MEDX with a GF Score™ of 67/100 and a GF Value™ of CHF8.96 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,851 Industrial Products companies, Medmix AG ranks better than 78.28% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Medmix AG's current 3-Year Share Buyback Ratio was 0.20%.
The historical rank and industry rank for Medmix AG's 3-Year Share Buyback Ratio or its related term are showing as below:
XSWX:MEDX'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: 0.1 Med: 0.3 Max: 0.4
Current: 0.2
During the past 8 years, Medmix AG's highest 3-Year Share Buyback Ratio was 0.40%. The lowest was 0.10%. And the median was 0.30%.
XSWX:MEDX's 3-Year Share Buyback Ratio is ranked better than 78.28% of 1851
companies
in the Industrial Products industry
Industry Median: -1.2
vs XSWX:MEDX: 0.20
Medmix AG (XSWX:MEDX) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Medmix AG 3-Year Share Buyback Ratio Related Terms
XSWX:MEDX vs GEV, ETN, PH: 3-Year Share Buyback Ratio Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG 3-Year Share Buyback Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Medmix AG's 3-Year Share Buyback Ratio falls into.
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.20 mean?
Medmix AG (XSWX:MEDX) has a 3-Year Share Buyback Ratio of 0.20 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Medmix AG and its competitors. This is 33% below median its historical median of 0.30. Over the past decade, Medmix AG's 3-Year Share Buyback Ratio has ranged from 0.10 to 0.40. According to the industry distribution chart, Medmix AG ranks #402 out of 1851 companies in the Industrial Products industry, placing it in the top 21.7%.
Is Medmix AG's 3-Year Share Buyback Ratio too high?
Medmix AG's current 3-Year Share Buyback Ratio of 0.20 is 33% below median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.40. Based on the distribution chart, Medmix AG ranks #402 out of 1851 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Medmix AG has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's 3-Year Share Buyback Ratio compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #402 out of 1851 companies for 3-Year Share Buyback Ratio. This places Medmix AG in the top 22% of its industry — outperforming the majority of peers. Historically, Medmix AG's own 3-Year Share Buyback Ratio has ranged from 0.10 to 0.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for an Industrial Products company?
A good 3-Year Share Buyback Ratio depends on the Industrial Products industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Medmix AG and its competitors. Medmix AG's current 3-Year Share Buyback Ratio is 0.20, which is 33% below median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (XSWX:MEDX) is currently considered Fairly Valued. The stock's GF Value™ is CHF8.96, compared to a current price of CHF8.93 — trading 0.3% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.20, which is 33% below median its 10-year median of 0.30. Medmix AG's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Medmix AG (XSWX:MEDX), the current 3-Year Share Buyback Ratio is 0.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (XSWX:MEDX) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.93 is trading 0.3% below its estimated GF Value™ of CHF8.96.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for XSWX:MEDX:
3-Year Share Buyback Ratio: 0.20 (33% below median its 10-year median of 0.30)
GF Value™: CHF8.96 vs. price of CHF8.93 (0.3% below fair value)
No single metric tells the full story. See the XSWX:MEDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
67GF Score
Get the complete analysis for XSWX:MEDX
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MEDX has been successfully added to your 
